These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 28629733)

  • 21. Interleukin-3 does not affect the differentiation of mast cells derived from human bone marrow progenitors.
    Shimizu Y; Matsumoto K; Okayama Y; Sakai K; Maeno T; Suga T; Miura T; Takai S; Kurabayashi M; Saito H
    Immunol Invest; 2008; 37(1):1-17. PubMed ID: 18214796
    [TBL] [Abstract][Full Text] [Related]  

  • 22. FK506 and cyclosporin A inhibit stem cell factor-dependent cell proliferation/survival, while inducing upregulation of c-kit expression in cells of the mast cell line MC/9.
    Ito F; Toyota N; Sakai H; Takahashi H; Iizuka H
    Arch Dermatol Res; 1999 May; 291(5):275-83. PubMed ID: 10367710
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of short term in vitro cultured human mast cells from different progenitors - Peripheral blood-derived progenitors generate highly mature and functional mast cells.
    Andersen HB; Holm M; Hetland TE; Dahl C; Junker S; Schiøtz PO; Hoffmann HJ
    J Immunol Methods; 2008 Jul; 336(2):166-74. PubMed ID: 18538784
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Haematopoietic action of flt3 ligand on cord blood-derived CD34-positive cells expressing different levels of flt3 or c-kit tyrosine kinase receptor: comparison with stem cell factor.
    Sakabe H; Kimura T; Zeng Z; Minamiguchi H; Tsuda S; Yokota S; Hodohara K; Abe T; Lyman SD; Sonoda Y
    Eur J Haematol; 1998 May; 60(5):297-306. PubMed ID: 9654159
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Stem cell factor has a suppressive activity to IgE-mediated chemotaxis of mast cells.
    Sawada J; Shimizu S; Tamatani T; Kanegasaki S; Saito H; Tanaka A; Kambe N; Nakahata T; Matsuda H
    J Immunol; 2005 Mar; 174(6):3626-32. PubMed ID: 15749900
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Early-acting cytokine-driven ex vivo expansion of mobilized peripheral blood CD34+ cells generates post-mitotic offspring with preserved engraftment ability in non-obese diabetic/severe combined immunodeficient mice.
    Herrera C; Sánchez J; Torres A; Bellido C; Rueda A; Alvarez MA
    Br J Haematol; 2001 Sep; 114(4):920-30. PubMed ID: 11564087
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Induction of telomerase activity during development of human mast cells from peripheral blood CD34+ cells: comparisons with tumor mast-cell lines.
    Chaves-Dias C; Hundley TR; Gilfillan AM; Kirshenbaum AS; Cunha-Melo JR; Metcalfe DD; Beaven MA
    J Immunol; 2001 Jun; 166(11):6647-56. PubMed ID: 11359819
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ex vivo expansion of megakaryocyte progenitors: effect of various growth factor combinations on CD34+ progenitor cells from bone marrow and G-CSF-mobilized peripheral blood.
    Gehling UM; Ryder JW; Hogan CJ; Hami L; McNiece I; Franklin W; Williams S; Helm K; King J; Shpall EJ
    Exp Hematol; 1997 Oct; 25(11):1125-39. PubMed ID: 9328449
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mast cell and myeloid marker expression during early in vitro mast cell differentiation from human peripheral blood mononuclear cells.
    Welker P; Grabbe J; Zuberbier T; Guhl S; Henz BM
    J Invest Dermatol; 2000 Jan; 114(1):44-50. PubMed ID: 10620114
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An increase in circulating mast cell colony-forming cells in asthma.
    Mwamtemi HH; Koike K; Kinoshita T; Ito S; Ishida S; Nakazawa Y; Kurokawa Y; Shinozaki K; Sakashita K; Takeuchi K; Shiohara M; Kamijo T; Yasui Y; Ishiguro A; Kawano Y; Kitano K; Miyazaki H; Kato T; Sakuma S; Komiyama A
    J Immunol; 2001 Apr; 166(7):4672-7. PubMed ID: 11254727
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Generation of a considerable number of functional mast cells with a high basal level of FcepsilonRI expression from cord blood CD34+ cells by co-culturing them with bone marrow stromal cell line under serum-free conditions.
    Yamaguchi M; Azuma H; Fujihara M; Hamada H; Ikeda H
    Scand J Immunol; 2007 Jun; 65(6):581-8. PubMed ID: 17523952
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Generation of a novel stem cell factor-dependent mast cell progenitor.
    Yuan Q; Gurish MF; Friend DS; Austen KF; Boyce JA
    J Immunol; 1998 Nov; 161(10):5143-6. PubMed ID: 9820483
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effects of stem cell factor on the ultrastructure of Fc epsilon RI+ cells developing in IL-3-dependent murine bone marrow-derived cell cultures.
    Rottem M; Goff JP; Albert JP; Metcalfe DD
    J Immunol; 1993 Nov; 151(9):4950-63. PubMed ID: 7691960
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Peripheral blood cultured mast cells: Phenotypic and functional outcomes of different culture protocols.
    Elst J; Sabato V; van der Poorten MM; Faber M; Van Gasse AL; De Puysseleyr LP; Bridts CH; Mertens C; Van Houdt M; Maurer M; Hagendorens MM; Ebo DG
    J Immunol Methods; 2021 May; 492():113003. PubMed ID: 33647250
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Detection of tryptase-, chymase+ cells in human CD34 bone marrow progenitors.
    Shimizu Y; Suga T; Maeno T; Tsukagoshi H; Kawata T; Narita T; Takahashi T; Ishikawa S; Morishita Y; Nakajima T; Hara F; Miura T; Kurabayashi M
    Clin Exp Allergy; 2004 Nov; 34(11):1719-24. PubMed ID: 15544596
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cultured human intestinal mast cells express functional IL-3 receptors and respond to IL-3 by enhancing growth and IgE receptor-dependent mediator release.
    Gebhardt T; Sellge G; Lorentz A; Raab R; Manns MP; Bischoff SC
    Eur J Immunol; 2002 Aug; 32(8):2308-16. PubMed ID: 12209644
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differentiation of human mast cells from bone-marrow and cord-blood progenitor cells by factors produced by a mouse stromal cell line.
    Arock M; Hervatin F; Guillosson JJ; Mencia-Huerta JM; Thierry D
    Ann N Y Acad Sci; 1994 May; 725():59-68. PubMed ID: 7518213
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Stem-cell factor, the kit ligand, induces direct degranulation of rat peritoneal mast cells in vitro and in vivo: dependence of the in vitro effect on period of culture and comparisons of stem-cell factor with other mast cell-activating agents.
    Taylor AM; Galli SJ; Coleman JW
    Immunology; 1995 Nov; 86(3):427-33. PubMed ID: 8550081
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inducible pluripotent stem cells to study human mast cell trajectories.
    Idelman G; Rizza CF; Marella S; Sharma A; Chakraborty S; Tay HL; Tomar S; Ganesan V; Schuler CF; Baker JR; Hogan SP
    Mucosal Immunol; 2024 Oct; 17(5):1029-1044. PubMed ID: 39038754
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cord blood CD34+ cells cultured with FLT3L, stem cell factor, interleukin-6, and IL-3 produce CD11c+CD1a-/c- myeloid dendritic cells.
    Fadilah SA; Vuckovic S; Khalil D; Hart DN
    Stem Cells Dev; 2007 Oct; 16(5):849-55. PubMed ID: 17999605
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.